TDAM USA’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,729
Closed -$234K 232
2020
Q1
$234K Sell
3,729
-1,800
-33% -$130K 0.02% 218
2019
Q4
$430K Sell
5,529
-15
-0.3% -$1.17K 0.03% 213
2019
Q3
$406K Sell
5,544
-18
-0.3% -$1.26K 0.03% 209
2019
Q2
$343K Sell
5,562
-45
-0.8% -$2.72K 0.02% 220
2019
Q1
$358K Buy
5,607
+9
+0.2% +$514 0.03% 214
2018
Q4
$286K Sell
5,598
-1,464
-21% -$74.1K 0.02% 275
2018
Q3
$325K Hold
7,062
0.02% 284
2018
Q2
$343K Buy
7,062
+642
+10% +$30K 0.02% 280
2018
Q1
$299K Buy
6,420
+789
+14% +$34.3K 0.02% 293
2017
Q4
$212K Buy
+5,631
New +$207K 0.01% 317
2017
Q1
Sell
-8,712
Closed -$272K 356
2016
Q4
$272K Sell
8,712
-3
-0% -$97 0.01% 302
2016
Q3
$350K Buy
8,715
+372
+4% +$14K 0.02% 311
2016
Q2
$277K Sell
8,343
-1,995
-19% -$68.3K 0.01% 318
2016
Q1
$304K Buy
+10,338
New +$285K 0.01% 316

Other funds holding EW

TDAM USA's EW Position: Q2 2020 in Review

TDAM USA sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 3,729 shares — an estimated $234K sold.

TDAM USA first reported a position in EW in Q1 2016 and held it in 14 quarters. The position peaked at $430K in Q4 2019. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • TDAM USA reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • TDAM USA sold 3,729 Edwards Lifesciences shares in Q2 2020, an estimated $234K.
  • TDAM USA first reported a position in Edwards Lifesciences in Q1 2016 and held it in 14 quarters.
  • TDAM USA's Edwards Lifesciences position peaked at $430K in Q4 2019.
  • 1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on TDAM USA's 13F filing for Q2 2020, filed 13 Aug 2020.